Theranostics Q1 Unclaimed
Theranostics is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology, Toxicology and Pharmaceutics (miscellaneous) with an H index of 136. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1525 €. The scope of the journal is focused on in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, personalized medicine. It has an SJR impact factor of 2,381 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,381.
Theranostics focuses its scope in these topics and keywords: cancer, nanoparticles, vivo, theranostic, tumor, breast, imaging, receptors, effect, activity, ...
Type: Journal
Type of Copyright: CC BY-NC
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
1525 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
2,381
SJR Impact factor136
H Index481
Total Docs (Last Year)1936
Total Docs (3 years)36518
Total Refs23868
Total Cites (3 years)1936
Citable Docs (3 years)12.06
Cites/Doc (2 years)75.92
Ref/DocOther journals with similar parameters
Annual Review of Public Health Q1
Annual Review of Pathology: Mechanisms of Disease Q1
The Lancet Global Health Q1
Annual Review of Clinical Psychology Q1
JAMA - Journal of the American Medical Association Q1
Compare this journals
Comments